A reduction in G i2 protein, but not G o and G s , expression has been described in cabergoline-resistant with respect to sensitive prolactinomas ( i13 proteins has been reported in GH-secreting tumors ( Alterations in SSTRs signal transduction might be the cause of typical octreotide-resistance observed in acromegalic patients bearing germline mutations in aryl hydrocarbon receptor interacting protein (AIP) gene ( i signaling ( Genetic analysis of AIP in 50 non-familial acromegalic patients resistant to treatment with SS analogs revealed a low, but non-negligible, prevalence of AIP germline mutations ( Fougner et al

In general, to qualify for a tirzepatide prescription you will need: BMI of 30 or higher BMI of 27 or higher + at least one weight-related condition (high blood pressure, high cholesterol, type 2 diabetes, etc.) Your provider will also take into account your medical history, prior weight-loss attempts, and family history to help you find the best weight-loss treatment for your
On April 15, 2026, the FDA updated its 503A bulk drug substances document, removing multiple peptides from Category 2 and scheduling them for PCAC evaluation
318 (4), G717G724